Propranolol in the treatment of problematic infantile hemangioma: Review of 35 consecutive patients from a vascular anomalies clinic

Journal of Cutaneous Medicine and Surgery

Volumn 16, Issue 2, 2012, Pages 115-121

  Bertrand, Janie ^a,b   Sammour, Rita ^a,b   McCuaig, Catherine ^a,b   Dubois, Josée ^a,b   Hatami, Afshin ^a,b   Ondrejchak, Sandra ^a,b   Boutin, Christine ^a,b   Bortoluzzi, Patricia ^a,b   Laberge, Louise C ^a,b   Powell, Julie ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; PROPRANOLOL;

ASYMPTOMATIC DISEASE; BODY WEIGHT DISORDER; BRADYCARDIA; CAPILLARY HEMANGIOMA; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; CORPUS CALLOSUM AGENESIS; DECREASED APPETITE; DIARRHEA; DOPPLER ECHOGRAPHY; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EARLY INTERVENTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPOTENSION; INCREASED APPETITE; INFANT; INFECTION; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NIGHTMARE; OUTPATIENT CARE; PATIENT MONITORING; PATIENT SELECTION; POOR WEIGHT GAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SIDE EFFECT; SKIN ULCER; SLEEP DISORDER; TREATMENT DURATION; TUMOR GROWTH;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; PATIENT SELECTION; PROPRANOLOL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84860338586     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2011.10117     Document Type: Review

References (12)

1. Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009;20 Suppl 1:678-84, doi:10.1097/SCS.0b013e318193d6c1.
2. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study in infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006;118:882-7, doi:10.1542/ peds.2006-0413.
3. Bennett ML, Fleischer AB Jr, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-13. (Pubitemid 32847844)
4. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005;22:383-406, doi:10.1111/j.1525-1470.2005.00102.x. (Pubitemid 43960991)
5. Enjolras O, Brevière GM, Roger G, et al. Traitement par vincristine des hémangiomes graves du nourrisson. Arch Pediatr 2004;11:99- 107, doi:10.1016/j.arcped.2003.10.014.
6. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51, doi:10.1056/NEJMc0708819.
7. Léauté-Labrèze C, Taïeb A. Efficacitédes bêtabloquants dans les hémangiomes capillaires infantiles: signification physiopathologique et conséquences thérapeutiques. Ann Dermatol Venereol 2008; 135:860-2, doi:10.1016/j.annder.2008.10.006.
8. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-7, doi:10.1542/peds.2007-2767.
9. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003;48:477-93, doi:10.1067/mjd.2003.200. (Pubitemid 36397008)
10. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124: e423-31, doi:10.1542/peds.2008-3458.
11. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846-7, doi:10.1056/NEJMc086443.
12. Lawley LP, Siegfried E, Todd JL. Propranolol treatment of hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-4, doi:10.1111/j.1525-1470.2009.00975.x.